Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

June 28-30 2020

Palliative Care 2020 Conf

June 28-30 2020

Euro Physics 2020

June 28-30 2020

NGNC 2020

April 29-30, 2020

18th European Pathology and Medicine Congress

Prague, Czech Republic
June 28-30 2020

generalcare-cs-2020

June 28-30 2020

holisticnursing-cs-2020

June 28-30 2020

Biotech 2020

August 26-27, 2020

World Congress on Histopathology & Cytopathology

Kyoto, Japan
September 16-17, 2020

7th Annual Meet on Cardiology and Heart diseases

Barcelona, Spain
September 24-25, 2020

Global Digital Pathology Summit

Paris, France
October 19-20, 2020

World Congress on Pathology and Microbiology

Manila, Philippines
October 19-20, 2020

Global Pathologists Meet

Manila, Philippines
November 02-03, 2020

Reproductive Medicine & Women Healthcare

Paris, France
November 25-26, 2020

18th Asia Pacific Pathology Congress

Tokyo, Japan

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in